Research into Parkinson's has made remarkable progress. There is very real hope that the causes, whether genetic or environmental, will be identified and the precise effects of these will be understood in the near future. In this section we aim to provide the Parkinson’s community with access to research into the causes of Parkinson's.

29 Apr 2020

Induced pluripotent stem cell modeling of young-onset Parkinson’s

Young-onset Parkinson’s (YOPD) accounts for 10% of all Parkinson’s. Some cases are associated with known genetic mutations, but most are not. Laperle and others used stem cells from individuals with YOPD without any known gene mutations including PD genes EIFG1, PARK2, LRRK2, GBA, SNCA, PINK1, PARK7, VSP35 and ATP13A2 or amplifications of the SNCA locus to grow functional dopamine secreting neurons. Even in the absence of known genetic mutations newly grown dopamine neurons showed increased accumulation of α-synuclein and other Parkinson’s signature pathologies. The α-synuclein accumulation was reduced with activation of proteasome enzymes or phorbol esters. This study shows that induced pluripotent stem cell modeling is promising in growing dopamine neurons. However, there are other unknown genetic contributions to this condition. In addition, they have raised another possible treatment solution to YOPD which is photbol esters, but much research is needed in the area.

14 May 2020

Inhaled McIntyre powder, which was used in the mining industry during the mid-20th century, is associated with an increased risk of Parkinson's disease, a study has found.

Please reload

The content of this web site is intended to convey general educational information and should not be relied upon as a substitute for professional healthcare advice. 

© 2020 by Parkinson's Australia, PO Box 108, Deakin West, ACT 2600

ABN 46 011 714 078   

Parkinson's Australia Privacy Policy

Search this site